HIV status is an independent risk factor for reporting lower urinary tract symptoms

Journal of Urology

Volumn 185, Issue 5, 2011, Pages 1710-1715

  Breyer, Benjamin N ^a   Van Den Eeden, Stephen K ^a   Horberg, Michael A ^b   Eisenberg, Michael L ^d   Deng, Donna Y ^d   Smith, James F ^d   Shindel, Alan W ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAISER PERMANENTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of California San Francisco ^*

Author keywords

HIV; signs and symptoms; urinary tract

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNATIONAL PROSTATE SYMPTOM SCORE; INTERNET; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SELF REPORT;

ADULT; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HUMANS; INTERNET; LOGISTIC MODELS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; STATISTICS, NONPARAMETRIC; URINATION DISORDERS;

EID: 79953793919     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.12.043     Document Type: Article

References (17)

1. H.I. Hall, R. Song, and P. Rhodes Estimation of HIV incidence in the United States JAMA 300 2008 520
2. H.I. Hall, T.A. Green, and R.J. Wolitski Estimated future HIV prevalence, incidence, and potential infections averted in the United States: a multiple scenario analysis J Acquir Immune Defic Syndr 55 2010 271
3. P.A. Volberding, and S.G. Deeks Antiretroviral therapy and management of HIV infection Lancet 376 2010 49
4. B. Grund, G. Peng, and C.L. Gibert Continuous antiretroviral therapy decreases bone mineral density Aids 23 2009 1519
5. B. Marin, R. Thiebaut, and H.C. Bucher Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy Aids 23 2009 1743
6. T. Ferry, F. Raffi, and F. Collin-Filleul Uncontrolled viral replication as a risk factor for non-AIDS severe clinical events in HIV-infected patients on long-term antiretroviral therapy: APROCO/COPILOTE (ANRS CO8) cohort study J Acquir Immune Defic Syndr 51 2009 407
7. R.O. Roberts, T. Rhodes, and L.A. Panser Natural history of prostatism: worry and embarrassment from urinary symptoms and health care-seeking behavior Urology 43 1994 621
8. J.F. Hermieu, V. Delmas, and L. Boccon-Gibod Micturition disturbances and human immunodeficiency virus infection J Urol 156 1996 157
9. C.J. Kane, D.M. Bolton, and J.A. Connolly Voiding dysfunction in human immunodeficiency virus infections J Urol 155 1996 523
10. A.T. Cockett, Y. Aso, and L. Denis World Health Organization Consensus Committee recommendations concerning the diagnosis of BPH Prog Urol 1 1991 957
11. M.J. Barry, F.J. Fowler Jr, and M.P. O'Leary The American Urological Association symptom index for benign prostatic hyperplasia The Measurement Committee of the American Urological Association J Urol 148 1992 1549
12. G. Welch, I. Kawachi, and M.J. Barry Distinction between symptoms of voiding and filling in benign prostatic hyperplasia: findings from the Health Professionals Follow-up Study Urology 51 1998 422
13. M.J. Barry, W.O. Williford, and F.J. Fowler Jr Filling and voiding symptoms in the American Urological Association symptom index: the value of their distinction in a Veterans Affairs randomized trial of medical therapy in men with a clinical diagnosis of benign prostatic hyperplasia J Urol 164 2000 1559
14. -1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults MMWR Recomm Rep 41 1992 1
15. J. Cuzick A Wilcoxon-type test for trend Stat Med 4 1985 87
16. L.H. Kuller, R. Tracy, and W. Belloso Inflammatory and coagulation biomarkers and mortality in patients with HIV infection PLoS Med 5 2008 e203
17. A.M. De Pinho, G.S. Lopes, and C.F. Ramos-Filho Urinary tract infection in men with AIDS Genitourin Med 70 1994 30